TATarek Atia

Tarek Atia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tarek Atia has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antigenic Drift and Immune Escape of Infectious Bursal Disease Viruses in Egypt: Molecular, Phylogenetic and Field Insights

    by Mahmoud Fawzan, Mona S. Abdallah, Wael K. Elfeil, Amira M. Helal, Adel Alghamdi, Tarek Atia, Hader I. Sakr, Ghadeer M. Albadrani, Hanan M. F. Abdien

    Infectious bursal disease virus (IBDV) remains a major constraint to poultry production due to its continuous evolution and impact on vaccine efficacy. This study investigated the molecular characteristics of circulating IBDV strains in Egypt and assessed their relationship with field vaccination outcomes. Bursa samples were collected from clinically IBD suspected broiler flocks (n = 50) across five Egyptian governorates. Real-time RT-PCR identified 34 positive samples, of which five representative isolates were selected based on geographic distribution and age (≤23 days). Genotyping revealed the co-circulation of three novel variants (A2dB1b), one very virulent strain (A3B2), and one classical virulent strain (A1B1a). Molecular characterization of both VP2 and VP1 genes demonstrated marked diversity from standard vaccine backbones. VP2 analysis identified multiple amino acid substitutions within key neutralizing epitopes in the novel variants, including a consistent substitution at residue 321, suggesting a potential molecular marker. The very virulent isolate exhibited a distinct VP2 hypervariable profile featuring a substitution at residue 222 alongside mutations at positions 254 and 324. VP1 analysis further identified variations associated with viral replication efficiency. Sequence comparison indicated considerable genetic divergence from commercial vaccines, while sharing key amino acid features with recombinant HVT-VP2-based and immune complex vaccine strategies. Field observations strongly supported these molecular findings, as their use, particularly in combination with live vaccines, reduced IBDV detection rates to 28.5% and 40%, respectively, while reaching 93–100% with intermediate live vaccines. Overall, these findings highlight the critical need for continuous VP2-HVR molecular surveillance to optimize vaccine matching under field conditions.

  • Metabolic Reprogramming in Endometrium During Menstrual Cycle and Its Relationship to Infertility

    by Mohammad H. Abdelzaher, Tarek Atia

    The human endometrium, a complex and dynamic tissue, experiences cyclical shedding, repair, regeneration, and modification in anticipation of embryo implantation. During the mid‐secretory phase, influenced by ovarian steroid hormones, it becomes briefly receptive. The functional layer of the endometrium, consisting of several cell types including epithelial, stromal, vascular, and immunological cells, is essential for reproduction as it prepares for implantation, sustains pregnancy, and enables menstruation. Progesterone generated during the secretory phase prepares the endometrium for blastocyst implantation. Decidualization, an essential component of endometrial remodeling, entails substantial cellular alterations vital for successful implantation. Metabolic reprogramming in the endometrium entails critical alterations in metabolic enzymes, metabolites, and pathways in reaction to environmental stimuli. Decidualization requires significant energy, leading to a major transformation in energy metabolism. This includes modifications in carbohydrate, lipid, and amino acid metabolism that support the development of decidual cells.


  • Echinochrome guarding effect against sodium arsenite-induced hepatorenal toxicity in rats

    by Hader I. Sakr, Tarek Atia, Neamat A. Mahmoud, Islam Ahmed Abdelmawgood, Marina Lotfy Khalaf, Bassam Waleed Ebeed, Ahmed Mohamed Abdelmohsen, Mohamed A. Kotb, Abdeljalil Mohamed Al Shawoush, Ahmed A. Damanhory, et al.


  • Efficacy of yeast-mediated SeNPs on gastric ulcer healing and gut microbiota dysbiosis in male albino rats

    by Aya Adel Fath-All, Tarek Atia, Ayman Saber Mohamed, Neveen M. Khalil, Tamer D. Abdelaziz, Neamat A. Mahmoud, Abdallah Mohammed Elagali, Hader I. Sakr, Mohamed N. Abd El-Ghany


  • Open Access

    Mesenchymal stem cells versus mesenchymal stem cells-derived exosomes as potential autophagy pathway modulators in a diabetic model

    by Fatma Y. Meligy, Hanan Sharaf El-Deen Mohammed, Amal T. Abou Elghait, Heba K. Mohamed, Israa El-Sayed Mohamed Ashry, Ayat Abdel-Rahman Sayed, Ola A. Hussein, Ahmed Salman, Tarek Atia, Abir S. Mohamed, et al.


  • Open Access

    Is thyroid dysfunction a common cause of telogen effluvium?: A retrospective study

    by Salman Bin Dayel, Ramadan S. Hussein, Tarek Atia, Othman Abahussein, Rand S. Al Yahya, Shereen H. Elsayed

    Telogen effluvium (TE) is a common cause of hair loss characterized by excessive resting hair shedding. Thyroid dysfunction is one of the possible causes of TE. On the other hand, the link between thyroid disorder and TE is still being debated. The aim of this retrospective is to investigate the link between thyroid dysfunction and TE. This retrospective study included 500 female patients with TE who had thyroid function testing between January 2012 and December 2022. Patients were eligible if they had a confirmed TE diagnosis and thyroid function tests within 3 months of being diagnosed with TE. The thyroid function of the participants was classified as euthyroid, hypothyroidism, or hyperthyroidism. The severity of hair loss was determined using the severity of alopecia tool (SALT) score. The study included 500 TE females, 248 of whom were euthyroid, 150 had hypothyroidism, and 102 had hyperthyroidism. The hypothyroid group had a significantly higher mean SALT score than the other 2 groups. Furthermore, patients in the hypothyroid group had a higher proportion of severe hair loss. The mean SALT score did not differ significantly between groups with normal thyroid function and those with hyperthyroidism. A common cause of TE is thyroid dysfunction, particularly hypothyroidism. Patients with hypothyroidism have more severe hair loss than those with normal thyroid function or hyperthyroidism. To effectively identify and manage such cases, thyroid function testing should be included in the diagnostic workup of patients with TE.


  • Open Access

    Hematopoietic effect of echinochrome on phenylhydrazine-induced hemolytic anemia in rats

    by Mona S. E. F. El-Shehry, Rafa A. Amrymi, Tarek Atia, Bassant M. M. Lotfy, Salma H. A. Ahmed, Sarah A. Qutb, Sara B. Ali, Ayman S. Mohamed, Mohamed R. Mousa, Ahmed A. Damanhory, et al.

    Background: Hemolytic anemia (HA) is a serious health condition resulting from reduced erythrocytes’ average life span. Echinochrome (Ech) is a dark-red pigment found in shells and spines of sea urchins. Aim: Studying the potential therapeutic effect of Ech on phenylhydrazine (PHZ)-induced HA in rats. Methods: Eighteen rats were divided into three groups (n = 6): the control group, the phenylhydrazine-induced HA group and the Ech group, injected intraperitoneally with PHZ and supplemented with oral Ech daily for 6 days. Results: Ech resulted in a considerable increase in RBCs, WBCs, and platelets counts, hemoglobin, reduced glutathione, catalase, and glutathione-S-transferase levels, and a significant decrease in aspartate & alanine aminotransferases, alkaline phosphatase, gamma-glutamyl transferase, bilirubin, creatinine, urea, urate, malondialdehyde & nitric oxide levels in anemic rats. Histopathological examination of liver and kidney tissue samples showed marked improvement. Conclusion: Ech ameliorated phenylhydrazine-induced HA with a hepatorenal protective effect owing to its anti-inflammatory and antioxidant properties.


  • Open Access

    Investigating the relationship between vitamin-D deficiency and glycemia status and lipid profile in nondiabetics and prediabetics in Saudi population

    by Tarek Atia, Mohammad H. Abdelzaher, Somaia A. Nassar, Hoda H. Msc Gafar, Mohammed A. M. Bsc Husseini, Abdulhadi M. Y. Bsc Kaabi, Hader I. Sakr

    Vitamin D deficiency increases the risk of developing diabetes, dyslipidemia, and other chronic diseases. We aimed to investigate the relationship between vitamin D deficiency, glycemic levels, and lipid profiles in individuals with prediabetes and nondiabetes. This observational cross-sectional study was conducted on 249 adults who were divided into 2 groups based on the American Diabetes Association classification: nondiabetics and prediabetics. The serum vitamin D levels, lipid profiles, fasting blood glucose levels, hemoglobin A1c levels, fasting insulin levels, and insulin resistance (IR) were evaluated. The prevalence of vitamin D deficiency in all participants was 30.9%, and mean vitamin D levels were significantly [P = .0004] lower in prediabetics, who were more common in females. Furthermore, prediabetics had significantly higher serum triglycerides [P = .0006], and significantly lower serum high-density lipoprotein levels [P = .0148] than those nondiabetics. Serum cholesterol and low-density lipoprotein levels did not differ significantly between the 2 groups. 31.4% of all participants were overweight and 40.2% were obese. Furthermore, there was a strong correlation between vitamin D levels and IR and body mass indices ≥ 25 in prediabetics [r = −0.92] [P < .001]. Finally, vitamin D levels had a significant inverse relationship with glycemic parameters and IR, particularly in obese participants, but there was no significant relationship with lipid profile. In conclusion, vitamin D deficiency is common in females, regardless of whether they are prediabetics, but is more prevalent in prediabetics. Vitamin D deficiency is associated with high triglycerides and low high-density lipoprotein levels, but there were no significant changes in total cholesterol or low-density lipoprotein levels. Furthermore, vitamin D levels were negatively correlated with both fasting blood glucose and hemoglobin A1c levels, and its deficiency was strongly associated with IR especially in obese patients despite there being no significant correlation with blood lipids.


  • Omentin roles in physiology and pathophysiology: an up-to-date comprehensive review

    by Aida A. Hussein, Noha A. Ahmed, Hader I. Sakr, Tarek Atia, Osama M. Ahmed

    Omentin (intelectin) was first detected in the visceral omental adipose tissue. It has mainly two isoforms, omentin-1 and -2, with isoform-1 being the main form in human blood. It possesses insulin-sensitizing, anti-inflammatory, anti-atherogenic, cardio-protective, and oxidative stress-decreasing effects. Omentin's cardiovascular protective actions are caused by the improved endothelial cell survival and function, increased endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) bioavailability, enhanced vascular smooth muscle cells (VSMCs) relaxation with reduced proliferation, decreased inflammation, and suppressed oxidative stress. Omentin may also have a potential role in different cancer types and rheumatic diseases. Thus, omentin is an excellent therapeutic target in many diseases, including diabetes mellitus (DM), metabolic syndrome (MetS), cardiovascular diseases (CVDs), inflammatory diseases, and cancer. This review demonstrates the physiological functions of omentin in ameliorating insulin resistance (IR), vascular function, and inflammation and its possible share in managing obesity-linked diseases, such as metabolic disorders, DM, and cardiovascular conditions.


  • Open Access

    Echinochrome Ameliorates Physiological, Immunological, and Histopathological Alterations Induced by Ovalbumin in Asthmatic Mice by Modulating the Keap1/Nrf2 Signaling Pathway

    by Islam Ahmed Abdelmawgood, Noha Ahmed Mahana, Abeer Mahmoud Badr, Ayman Saber Mohamed, Abdeljalil Mohamed Al Shawoush, Tarek Atia, Amir Elhadi Abdelrazak, Hader I. Sakr

    Asthma is a persistent inflammatory disease of the bronchi characterized by oxidative stress, airway remodeling, and inflammation. Echinochrome (Ech) is a dark-red pigment with antioxidant and anti-inflammatory activities. In this research, we aimed to investigate the effects of Ech against asthma-induced inflammation, oxidative stress, and histopathological alterations in the spleen, liver, and kidney in mice. Mice were divided into four groups (n = 8 for each): control, asthmatic, and asthmatic mice treated intraperitoneally with 0.1 and 1 mg/kg of Ech. In vitro, findings confirmed the antioxidant and anti-inflammatory activities of Ech. Ech showed antiasthmatic effects by lowering the serum levels of immunoglobulin E (IgE), interleukin 4 (IL-4), and interleukin 1β (IL-1β). It attenuated oxidative stress by lowering malondialdehyde (MDA) and nitric oxide (NO) contents and increasing reduced glutathione (GSH), superoxide dismutase (SOD), glutathione-s-transferase (GST), and catalase (CAT) in the liver, spleen, and kidney. Moreover, it protected asthma-induced kidney and liver functions by increasing total protein and albumin and decreasing aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, urea, and uric acid levels. Additionally, it ameliorated histopathological abnormalities in the lung, liver, spleen, and kidney. Additionally, molecular docking studies were used to examine the interactions between Ech and Kelch-like ECH-associated protein 1 (Keap1). PCR and Western blot analyses confirmed the association of Ech with Keap1 and, consequently, the regulatory role of Ech in the Keap1-(nuclear factor erythroid 2-related factor 2) Nrf2 signaling pathway in the liver, spleen, and kidney. According to our findings, Ech prevented asthma and its complications in the spleen, liver, and kidney. Inhibition of inflammation and oxidative stress are two of echinochrome’s therapeutic actions in managing asthma by modulating the Keap1/Nrf2 signaling pathway.